Joby Aviation Q2 earnings: revenue beats on Blade growth as eVTOL certification advances; 2026 passenger target and raised ...
Dine Brands Global reported Q2 2026 revenue above expectations, but EPS and adjusted EPS missed analyst estimates. Read more ...
Rigel Pharmaceuticals in-licensed Veppanu, a drug for the treatment of certain breast cancer patients, targeting a $1B market ...
Q4 FY2026 earnings call highlights: record results, datacenter growth, $93.9B NBMs, and Q1 FY2027 guidance—read insights now.
Q2 2026 earnings call recap: timing-driven model uplift miss, strong Q3 guide, AI compute costs, buybacks, SEC cleared—read now.
Schwab US Dividend Equity ETF may offer a safer way to keep diversified equity exposure amid macro risk. Click here to read ...
Braskem (BAK) faces default risk, leverage and liquidity stress, and likely equity wipeout amid industry headwinds. Read here ...
The Madison Small Cap Fund returned 12.7% in Q2 2026, trailing benchmarks as tech and healthcare sectors surged. Read the ...
DIVO's selective covered call strategy targets only 20–30% of holdings, preserving capital appreciation. Read why DIVO ETF is ...
High-yield bonds advanced in the second quarter as geopolitical tensions eased, helping stabilize energy prices and temper ...
July 2026 was a flattish month for markets. On our machine learning forecasting models, we see asset class after asset class ...
Rithm Capital's preferred shares have caught investor attention. Read more on the differences between each preferred.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results